Latest filings (excl ownership)
15-12B
Securities registration termination
25 Nov 14
EFFECT
Notice of effectiveness
21 Nov 14
POS AM
Prospectus update (post-effective amendment)
20 Nov 14
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Nov 14
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Nov 14
8-K
Completion of Acquisition or Disposition of Assets
17 Nov 14
SC 14D9/A
Tender offer solicitation (amended)
13 Nov 14
25-NSE
Exchange delisting
12 Nov 14
SC TO-T/A
Third party tender offer statement (amended)
12 Nov 14
SC 14D9/A
Tender offer solicitation (amended)
29 Oct 14
SC TO-T/A
Third party tender offer statement (amended)
28 Oct 14
UPLOAD
Letter from SEC
22 Oct 14
SC 14D9/A
Tender offer solicitation (amended)
15 Oct 14
SC TO-T/A
Third party tender offer statement (amended)
15 Oct 14
SC 14D9
Tender offer solicitation
10 Oct 14
SC TO-T
Third party tender offer statement
10 Oct 14
SC TO-C
Information about tender offer
30 Sep 14
8-K
Entry into a Material Definitive Agreement
29 Sep 14
SC TO-C
Information about tender offer
29 Sep 14
SC TO-C
Information about tender offer
29 Sep 14
SC TO-C
Information about tender offer
29 Sep 14
SC14D9C
Written communication relating to third party tender offer
29 Sep 14
SC14D9C
Written communication relating to third party tender offer
29 Sep 14
SC14D9C
Written communication relating to third party tender offer
29 Sep 14
8-K
Amendments to Articles of Incorporation or Bylaws
4 Sep 14
424B3
Prospectus supplement
26 Aug 14
EFFECT
Notice of effectiveness
26 Aug 14
10-Q
2014 Q2
Quarterly report
12 Aug 14
8-K
Results of Operations and Financial Condition
12 Aug 14
S-3
Shelf registration
12 Aug 14
S-8
Registration of securities for employees
12 Aug 14
8-K
Departure of Directors or Certain Officers
4 Jun 14
8-K
Departure of Directors or Certain Officers
19 May 14
10-Q
2014 Q1
Quarterly report
6 May 14
8-K
Results of Operations and Financial Condition
6 May 14
DEF 14A
Definitive proxy
9 Apr 14
10-K
2013 FY
Annual report
20 Mar 14
8-K
Ambit Biosciences Announces Fourth Quarter and Full-year 2013 Operating Results
20 Mar 14
8-K
Departure of Directors or Certain Officers
27 Jan 14
Latest ownership filings
SC 13G/A
Ambit Biosciences Corp
10 Dec 14
SC 13D/A
Ambit Biosciences Corp
19 Nov 14
SC 13G
Ambit Biosciences Corp
24 Oct 14
SC 13G/A
Ambit Biosciences Corp
9 Sep 14
SC 13G
Ambit Biosciences Corp
7 Jul 14
SC 13D
Beneficial ownership report
19 Mar 14
SC 13G
Ambit Biosciences Corp
14 Feb 14
SC 13G/A
Ambit Biosciences Corp
14 Feb 14
SC 13G/A
Ambit Biosciences Corp
14 Feb 14
SC 13G
Ambit Biosciences Corp
13 Feb 14
SC 13G
Ambit Biosciences Corp
10 Feb 14
SC 13G/A
Ambit Biosciences Corp
27 Dec 13
SC 13D/A
Beneficial ownership report (amended)
11 Sep 13
SC 13G
Ambit Biosciences Corp
24 Jun 13
SC 13D
Beneficial ownership report
31 May 13
SC 13D
Ambit Biosciences Corp
31 May 13
SC 13D
Ambit Biosciences Corp
30 May 13
SC 13G
Ambit Biosciences Corp
28 May 13
SC 13G
Ambit Biosciences Corp
24 May 13